Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Post by Cutmanon Mar 29, 2021 4:25pm
340 Views
Post# 32900248

2.33% up and 372K volume

2.33% up and 372K volume
Not an impressive day for Aristotle pre-lauch.
Facts are:
- They have no choice to release 2020 Q4 by March 31st midnight or ask IIROC for a delay
- Update shareholders regarding aristotle launch which was promised many time in interviews for 2021 Q1
- Voting card will be posted by mail for registered shareholders as of today
- Consider the DD from Tyler, Lithlover and Skirt a bonus. Obviously, these extra links and info don't affect volume, shareprice and big investors
- SZLS is getting ready with what we have seen over the week-end
- Hold your shares and if aristotle is delay, it will be an opportunity to load one last time

Tomorrow might THE day
 GLTA
<< Previous
Bullboard Posts
Next >>